Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study

BackgroundCardiovascular-kidney-metabolic (CKM) syndrome reflects the interplay among metabolic risk factors, chronic kidney disease, and cardiovascular disease (CVD). While the hemoglobin glycation index (HGI) has demonstrated prognostic value for cardiovascular events, its clinical utility remains...

Full description

Saved in:
Bibliographic Details
Main Authors: Huiyi Liu, Shuai Mao, Yunzhang Zhao, Lisha Dong, Yifan Wang, Chao Lv, Tong Yin
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1554032/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850148564565491712
author Huiyi Liu
Shuai Mao
Shuai Mao
Yunzhang Zhao
Yunzhang Zhao
Lisha Dong
Lisha Dong
Yifan Wang
Yifan Wang
Chao Lv
Tong Yin
Tong Yin
author_facet Huiyi Liu
Shuai Mao
Shuai Mao
Yunzhang Zhao
Yunzhang Zhao
Lisha Dong
Lisha Dong
Yifan Wang
Yifan Wang
Chao Lv
Tong Yin
Tong Yin
author_sort Huiyi Liu
collection DOAJ
description BackgroundCardiovascular-kidney-metabolic (CKM) syndrome reflects the interplay among metabolic risk factors, chronic kidney disease, and cardiovascular disease (CVD). While the hemoglobin glycation index (HGI) has demonstrated prognostic value for cardiovascular events, its clinical utility remains unexplored in early-stage CKM syndrome.MethodsParticipants with early-stage CKM syndrome (stage 0-3) were recruited from the China Health and Retirement Longitudinal Study (CHARLS) database. Using k-means clustering analysis, the participants were classified according to the values of HGI measured at baseline and 3 years later, respectively. The primary outcome was self-reported CVD during the follow-up of at least 3 years. Extreme gradient boosting (XGBoost) algorithm was applied, with the Shapley additive explanation (SHAP) method used to determine feature importance. Multivariable logistics proportional regression analysis the association between HGI and CVD, and restricted cubic spline (RCS) regression assessed potential nonlinear relationships.ResultsA total of 4676 eligible participants were included in the final analysis, with 944 (20.19%) progressed to CVD within 10 years. Among the baseline clinical features, HGI ranked the second for the impact on the occurrence of CVD. According to the changes of HGI values, the participants were clustered into 4 classes. Compared to the class 1 with lower level of HGI, higher risk of CVD was observed in class 3 (adjusted OR: 1.34, 95% CI: 1.06-1.69, P = 0.013) and class 4 (adjusted OR: 1.65, 95% CI: 1.01-2.45, P = 0.025) with higher and rapidly increasing level of HGI. RCS analysis showed cumulative HGI and the risk of CVD were linearly related (P for nonlinearity = 0.967). Subgroup analyses confirmed the stability of the association. Additionally, the SHAP plot revealed that HGI were the more important features than traditional risk factors such as FBG for predicting CVD.ConclusionHGI is associated with an elevated risk of CVD in participants with early-stage CKM syndrome. HGI can serve as an independent biomarker for guiding clinical decision-making and managing patient outcomes.
format Article
id doaj-art-3282980b98b24e159c84959f0ca312bf
institution OA Journals
issn 1664-2392
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-3282980b98b24e159c84959f0ca312bf2025-08-20T02:27:13ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-05-011610.3389/fendo.2025.15540321554032Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal studyHuiyi Liu0Shuai Mao1Shuai Mao2Yunzhang Zhao3Yunzhang Zhao4Lisha Dong5Lisha Dong6Yifan Wang7Yifan Wang8Chao Lv9Tong Yin10Tong Yin11Institute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaMedical School of Chinese PLA, Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaMedical School of Chinese PLA, Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaMedical School of Chinese PLA, Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaMedical School of Chinese PLA, Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaInstitute of Geriatrics, Beijing Key Laboratory of Research on Comorbidity in the Elderly, National Clinical Research Center for Geriatric Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing, ChinaMedical School of Chinese PLA, Chinese PLA General Hospital, Beijing, ChinaBackgroundCardiovascular-kidney-metabolic (CKM) syndrome reflects the interplay among metabolic risk factors, chronic kidney disease, and cardiovascular disease (CVD). While the hemoglobin glycation index (HGI) has demonstrated prognostic value for cardiovascular events, its clinical utility remains unexplored in early-stage CKM syndrome.MethodsParticipants with early-stage CKM syndrome (stage 0-3) were recruited from the China Health and Retirement Longitudinal Study (CHARLS) database. Using k-means clustering analysis, the participants were classified according to the values of HGI measured at baseline and 3 years later, respectively. The primary outcome was self-reported CVD during the follow-up of at least 3 years. Extreme gradient boosting (XGBoost) algorithm was applied, with the Shapley additive explanation (SHAP) method used to determine feature importance. Multivariable logistics proportional regression analysis the association between HGI and CVD, and restricted cubic spline (RCS) regression assessed potential nonlinear relationships.ResultsA total of 4676 eligible participants were included in the final analysis, with 944 (20.19%) progressed to CVD within 10 years. Among the baseline clinical features, HGI ranked the second for the impact on the occurrence of CVD. According to the changes of HGI values, the participants were clustered into 4 classes. Compared to the class 1 with lower level of HGI, higher risk of CVD was observed in class 3 (adjusted OR: 1.34, 95% CI: 1.06-1.69, P = 0.013) and class 4 (adjusted OR: 1.65, 95% CI: 1.01-2.45, P = 0.025) with higher and rapidly increasing level of HGI. RCS analysis showed cumulative HGI and the risk of CVD were linearly related (P for nonlinearity = 0.967). Subgroup analyses confirmed the stability of the association. Additionally, the SHAP plot revealed that HGI were the more important features than traditional risk factors such as FBG for predicting CVD.ConclusionHGI is associated with an elevated risk of CVD in participants with early-stage CKM syndrome. HGI can serve as an independent biomarker for guiding clinical decision-making and managing patient outcomes.https://www.frontiersin.org/articles/10.3389/fendo.2025.1554032/fullHGIglycemic variabilitycardiovascular kidney metabolic syndromeCVDCHARLS
spellingShingle Huiyi Liu
Shuai Mao
Shuai Mao
Yunzhang Zhao
Yunzhang Zhao
Lisha Dong
Lisha Dong
Yifan Wang
Yifan Wang
Chao Lv
Tong Yin
Tong Yin
Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
Frontiers in Endocrinology
HGI
glycemic variability
cardiovascular kidney metabolic syndrome
CVD
CHARLS
title Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
title_full Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
title_fullStr Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
title_full_unstemmed Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
title_short Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
title_sort association between hemoglobin glycation index and the risk of cardiovascular disease in early stage cardiovascular kidney metabolic syndrome evidence from the china health and retirement longitudinal study
topic HGI
glycemic variability
cardiovascular kidney metabolic syndrome
CVD
CHARLS
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1554032/full
work_keys_str_mv AT huiyiliu associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT shuaimao associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT shuaimao associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT yunzhangzhao associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT yunzhangzhao associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT lishadong associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT lishadong associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT yifanwang associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT yifanwang associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT chaolv associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT tongyin associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy
AT tongyin associationbetweenhemoglobinglycationindexandtheriskofcardiovasculardiseaseinearlystagecardiovascularkidneymetabolicsyndromeevidencefromthechinahealthandretirementlongitudinalstudy